Sagimet Biosciences Inc. Class A SGMT
NASDAQ · United States · Health Technology
$9.65-0.23 (-2.33%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.26 | -0.25 | -3.6% | $0 | — | -1.9%$9.57→$9.39 |
| Q1 2026 | 2026-05-12 | -0.33 | -0.35 | +5.7% | — | — | -1.2%$7.69→$7.60 |
| Q4 2025 | 2026-03-11 | -0.29 | -0.40 | +27.5% | — | — | -3.4%$5.53→$5.34 |
| Q3 2025 | 2025-11-13 | -0.40 | -0.39 | -2.6% | — | — | -12.1%$8.82→$7.75 |
| Q2 2025 | 2025-08-13 | -0.32 | -0.50 | +36.0% | — | — | — |
| Q4 2024 | 2025-03-12 | -0.50 | -0.59 | +15.3% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.45 | -0.40 | -12.5% | — | — | — |
| Q2 2024 | 2024-08-14 | -0.25 | -0.35 | +28.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.